Companies · Other Health Care

PTSH Holdings, LLC

NEW YORK · Other Health Care

Diligence memoA one-page analyst read on PTSH Holdings, LLC — recommendation, valuation, rhythm, risks.
$42.3M
Total raised · real
1
Rounds
Latest step-up
Top 10%
Sector rank · raised
Series C
Latest stage · inferred · Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

PTSH Holdings, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.93× the median modeled value of Series C Other Health Care companies in 2016–2018 (40 peers) — value vs value, same stage and era.
  • Within the normal band (93% of peer median) for its niche.
Dormant
  • Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

PTSH Holdings, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
8.1 yr record
Peak capital year was 2018 with $42.3M across 1 filings.
Market position
ahead of 91% of Other Health Care peers
Capital scale is ahead of 91% of Other Health Care peers; modeled value is above 96% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2018: $42.3M across 1 filings.
  • Largest single filing was $42.3M on 2018-06-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

PTSH Holdings, LLC is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 91% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
15
Investors (latest)
2013
Year incorporated
2018-06-01
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries C · 2018-06-01 Raised $42M (real) Modeled valuation $967M (est)$42M$967MSeries C2018

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$42.3M · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$967.1M
Base estimate est.
$153.7M
Conservative case
$2.5B
Upside case
$282.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.29×/yr
Annual markup
1.48×/yr upside case
6.0 yr
Elapsed time used
8.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
8.1 yr
On record since
2018
First round
1
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 17× above median
This company$42.3M
Sector median$2.4M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.9× of median
This company$42.3M
Sector median$45.9M
Modeled value — vs sector median (estimate, all stages) 44× above median
This company$967.1M
Sector median$22.1M

Raised more than 91% of sector peers (real $). Modeled value above 96% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #28 of 40.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Specialty Networks, LLC · Series C Raised $94.5M · modeled $2.2B (est)New MMI Holdings, Inc. · Series C Raised $80.7M · modeled $1.8B (est)BioMatrix Holdings, L.L.C. · Series C Raised $80.0M · modeled $1.8B (est)Sea Hunter Holdings, LLC · Series C Raised $76.3M · modeled $1.7B (est)Bind Benefits, Inc. · Series C Raised $70.0M · modeled $1.6B (est)Endotronix Inc · Series C Raised $116.1M · modeled $1.6B (est)Great Basin Scientific, Inc. · Series C Raised $124.3M · modeled $1.6B (est)TransMedics, Inc. · Series C Raised $249.0M · modeled $1.5B (est)Landmark Health, LLC · Series C Raised $90.8M · modeled $1.4B (est)Rapid Micro Biosystems, Inc. · Series C Raised $134.6M · modeled $1.4B (est)Mdp Acm Holdings, Llc · Series C Raised $60.0M · modeled $1.4B (est)ACON BioMatrix Investors I, L.L.C. · Series C Raised $57.5M · modeled $1.3B (est)PTSH Holdings, LLC (this company) Raised $42.3M · modeled $967.1M (est)PTSH Holdings, LLC
CompanyStageRaised · realValue · estvs peer med.
Specialty Networks, LLCSeries C$94.5M$2.2B2.08×
New MMI Holdings, Inc.Series C$80.7M$1.8B1.77×
BioMatrix Holdings, L.L.C.Series C$80.0M$1.8B1.76×
Sea Hunter Holdings, LLCSeries C$76.3M$1.7B1.68×
Bind Benefits, Inc.Series C$70.0M$1.6B1.54×
Endotronix IncSeries C$116.1M$1.6B1.52×
Great Basin Scientific, Inc.Series C$124.3M$1.6B1.49×
TransMedics, Inc.Series C$249.0M$1.5B1.40×
Landmark Health, LLCSeries C$90.8M$1.4B1.34×
Rapid Micro Biosystems, Inc.Series C$134.6M$1.4B1.32×
Mdp Acm Holdings, LlcSeries C$60.0M$1.4B1.32×
ACON BioMatrix Investors I, L.L.C.Series C$57.5M$1.3B1.26×
PTSH Holdings, LLC this companySeries C$42.3M$967.1M0.93×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$42.3M2018-06-01$282.0M$967.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$42.3M2018-06-01
    • First recorded raise — entered as Series C.
    • 15 investors on this round.
Intelligence
Modeled next raise
$67.7M
Modeled next size est.range $44.0M$108.3M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Ali Nensi1 other2018-06
Chris Laitala2018-06
Dale Yake2018-06
Jessica Yuan2018-06
Rocky Barnes2018-06
Registry & provenance

PTSH Holdings, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1744271
SEC CIK
2013
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
PhyMed Holdings, LLCOther Health CareSeries C$42.0M$960.2Msame sector · same stage
Sees Holdings, LlcOther Health CareSeries C$43.6M$996.9Msame sector · same stage
AHS VenturesOther Health CareSeries C$41.0M$405.2Msame sector · same stage
Phoenix Life Sciences International Limited.Other Health CareSeries C$40.9M$914.5Msame sector · same stage
United Vision Partners Holdings, LlcOther Health CareSeries C$44.1M$1.0Bsame sector · same stage
USHW Holdings CorpOther Health CareSeries C$40.5M$925.9Msame sector · same stage
Nuvasive IncOther Health CareSeries C$40.5M$925.1Msame sector · same stage
Avicena North America Inc.Other Health CareSeries C$44.4M$652.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
TCH Group, Inc.Other Health CareSeries B$487.9M85%
Magnolia (MH) Holdings, L.P.Other Health CareSeries D+$4.4B85%
TargetCath, Inc.Other Health CarePre-Seed$223K84%
USDH Parent, LLCOther Health CareSeed$2.9M84%
MCH Ventures, Inc.Other Health CareSeed$7.1M84%
Dhh LlcOther Health CarePre-Seed$2.2M84%
MedPharm Holdings, LLCOther Health CareSeries A$100.9M84%
FSM Equity Holdings, LLCOther Health CarePre-Seed$4.2M84%
Frequently asked
How much funding has PTSH Holdings, LLC raised?
PTSH Holdings, LLC has raised approximately $42.3M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is PTSH Holdings, LLC's estimated valuation?
Provath's modeled valuation for PTSH Holdings, LLC is approximately $967.1M (modeled range $153.7M–$2.5B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is PTSH Holdings, LLC at?
PTSH Holdings, LLC's latest modeled financing stage is Series C. Its most recent recorded round closed around Fri Jun 01.
What does PTSH Holdings, LLC do and where is it based?
PTSH Holdings, LLC operates in the Other Health Care sector, based in NEW YORK.
Explore related

See where PTSH Holdings, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at PTSH Holdings, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.